1. Home
  2. SNDX vs SFL Comparison

SNDX vs SFL Comparison

Compare SNDX & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • SFL
  • Stock Information
  • Founded
  • SNDX 2005
  • SFL 2003
  • Country
  • SNDX United States
  • SFL Bermuda
  • Employees
  • SNDX N/A
  • SFL N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • SFL Marine Transportation
  • Sector
  • SNDX Health Care
  • SFL Consumer Discretionary
  • Exchange
  • SNDX Nasdaq
  • SFL Nasdaq
  • Market Cap
  • SNDX 1.4B
  • SFL 1.7B
  • IPO Year
  • SNDX 2016
  • SFL N/A
  • Fundamental
  • Price
  • SNDX $13.63
  • SFL $10.06
  • Analyst Decision
  • SNDX Strong Buy
  • SFL Strong Buy
  • Analyst Count
  • SNDX 11
  • SFL 2
  • Target Price
  • SNDX $37.64
  • SFL $14.50
  • AVG Volume (30 Days)
  • SNDX 1.9M
  • SFL 823.0K
  • Earning Date
  • SNDX 11-05-2024
  • SFL 02-12-2025
  • Dividend Yield
  • SNDX N/A
  • SFL 10.95%
  • EPS Growth
  • SNDX N/A
  • SFL 39.68
  • EPS
  • SNDX N/A
  • SFL 1.10
  • Revenue
  • SNDX $16,000,000.00
  • SFL $876,068,000.00
  • Revenue This Year
  • SNDX N/A
  • SFL $21.02
  • Revenue Next Year
  • SNDX N/A
  • SFL N/A
  • P/E Ratio
  • SNDX N/A
  • SFL $8.99
  • Revenue Growth
  • SNDX N/A
  • SFL 19.50
  • 52 Week Low
  • SNDX $13.26
  • SFL $9.67
  • 52 Week High
  • SNDX $25.34
  • SFL $14.62
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 30.64
  • SFL 35.59
  • Support Level
  • SNDX $13.36
  • SFL $9.67
  • Resistance Level
  • SNDX $14.18
  • SFL $10.68
  • Average True Range (ATR)
  • SNDX 0.81
  • SFL 0.21
  • MACD
  • SNDX -0.18
  • SFL -0.06
  • Stochastic Oscillator
  • SNDX 11.32
  • SFL 27.14

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About SFL SFL Corporation Ltd

SFL Corp Ltd is an international ship owning and chartering company. The company is engaged primarily in the ownership and operation of vessels and offshore related assets and is also involved in the charter, purchase, and sale of assets. Its oil tankers, chemical tankers, and oil product tankers are all double-hull vessels.

Share on Social Networks: